Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › EFV

EFV

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of EFV

2 trials tracked of EFV.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. Completed
  2. Phase 2 Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Nomogram using baseline SUA and CD4+ count predicts hyperuricemia risk in people living with HIV
Diabetes & Endocrinology Cohort
Nomogram using baseline SUA and CD4+ count predicts hyperuricemia risk in people living with HIV What raises uric acid in HIV? New tool spots risk before symptoms start
This retrospective single-center study in Hangzhou, China derived and internally validated a nomogram predicting time to hyperuricemia (HUA)…
A new tool predicts high uric acid risk in HIV patients using just two factors: starting uric acid levels and CD4+ T-cell counts.
Frontiers Apr 16, 2026